Home > > > > > Report Detail

Global Oncology Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 26-Sep-2022
No. of pages: 129
Inquire Before Buying

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Oncology Drugs market is projected to reach US$ 395270 million by 2028 from an estimated US$ 219500 million in 2022, at a CAGR of 10.3% during 2023 and 2028.

The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Oncology Drugs.

The Oncology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oncology Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Roche

- Celgene

- Novartis

- Bristol-Myers Squibb

- Johnson & Johnson

- Merck & Co.

- AstraZeneca

- Pfizer

- Amgen

- Eli Lilly

- AbbVie

- Takeda

- Astellas

- Ipsen

- Sanofi

- Bayer

- Biogen Idec

- Teva

- Otsuka

- Eisai

- Merck KGaA

- Gilead Sciences

Product Type Insights

Global markets are presented by Oncology Drugs type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Oncology Drugs are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Oncology Drugs Segment by Type

- Chemotherapy

- Targeted Therapy

- Immunotherapy (Biologic Therapy)

- Hormonal Therapy

- Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Oncology Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Oncology Drugs market.

Oncology Drugs Segment by Application

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory or Lung Cancer

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Oncology Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Oncology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Oncology Drugs industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Drugs.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Oncology Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Oncology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Drugs Market Size Estimates and Forecasts
2.2 Oncology Drugs Market Size by Region: 2022 Versus 2028
2.2.1 Global Oncology Drugs Revenue by Region: 2017-2022
2.2.2 Global Oncology Drugs Revenue Forecast by Region (2023-2028)
2.2.3 Global Oncology Drugs Revenue Market Share by Region (2017-2028)
3 Global Oncology Drugs by Company
3.1 Global Oncology Drugs Revenue by Company (2017-2022)
3.2 Global Oncology Drugs Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Oncology Drugs Companies around the World: Ranking by Revenue
3.3.2 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Oncology Drugs Companies Headquarters & Product Type
3.4.1 Oncology Drugs Companies Headquarters
3.4.2 Global Oncology Drugs Companies Product & Service
3.4.3 Date of International Companies Enter into Oncology Drugs Market
3.5 Global Oncology Drugs Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Roche
4.1.1 Roche Corporation Information
4.1.2 Roche Description, Business Overview
4.1.3 Roche Oncology Drugs Products Offered
4.1.4 Roche Oncology Drugs Revenue and Gross Margin (2017-2022)
4.1.5 Roche Oncology Drugs Revenue by Product in 2021
4.1.6 Roche Oncology Drugs Revenue by Application in 2021
4.1.7 Roche Oncology Drugs Revenue by Geographic Area in 2021
4.1.8 Roche Recent Developments
4.2 Celgene
4.2.1 Celgene Corporation Information
4.2.2 Celgene Description, Business Overview
4.2.3 Celgene Oncology Drugs Products Offered
4.2.4 Celgene Oncology Drugs Revenue and Gross Margin (2017-2022)
4.2.5 Celgene Oncology Drugs Revenue by Product in 2021
4.2.6 Celgene Oncology Drugs Revenue by Application in 2021
4.2.7 Celgene Oncology Drugs Revenue by Geographic Area in 2021
4.2.8 Celgene Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Oncology Drugs Products Offered
4.3.4 Novartis Oncology Drugs Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Oncology Drugs Revenue by Product in 2021
4.3.6 Novartis Oncology Drugs Revenue by Application in 2021
4.3.7 Novartis Oncology Drugs Revenue by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 Bristol-Myers Squibb
4.4.1 Bristol-Myers Squibb Corporation Information
4.4.2 Bristol-Myers Squibb Description, Business Overview
4.4.3 Bristol-Myers Squibb Oncology Drugs Products Offered
4.4.4 Bristol-Myers Squibb Oncology Drugs Revenue and Gross Margin (2017-2022)
4.4.5 Bristol-Myers Squibb Oncology Drugs Revenue by Product in 2021
4.4.6 Bristol-Myers Squibb Oncology Drugs Revenue by Application in 2021
4.4.7 Bristol-Myers Squibb Oncology Drugs Revenue by Geographic Area in 2021
4.4.8 Bristol-Myers Squibb Recent Developments
4.5 Johnson & Johnson
4.5.1 Johnson & Johnson Corporation Information
4.5.2 Johnson & Johnson Description, Business Overview
4.5.3 Johnson & Johnson Oncology Drugs Products Offered
4.5.4 Johnson & Johnson Oncology Drugs Revenue and Gross Margin (2017-2022)
4.5.5 Johnson & Johnson Oncology Drugs Revenue by Product in 2021
4.5.6 Johnson & Johnson Oncology Drugs Revenue by Application in 2021
4.5.7 Johnson & Johnson Oncology Drugs Revenue by Geographic Area in 2021
4.5.8 Johnson & Johnson Recent Developments
4.6 Merck & Co.
4.6.1 Merck & Co. Corporation Information
4.6.2 Merck & Co. Description, Business Overview
4.6.3 Merck & Co. Oncology Drugs Products Offered
4.6.4 Merck & Co. Oncology Drugs Revenue and Gross Margin (2017-2022)
4.6.5 Merck & Co. Oncology Drugs Revenue by Product in 2021
4.6.6 Merck & Co. Oncology Drugs Revenue by Application in 2021
4.6.7 Merck & Co. Oncology Drugs Revenue by Geographic Area in 2021
4.6.8 Merck & Co. Recent Development
4.7 AstraZeneca
4.7.1 AstraZeneca Corporation Information
4.7.2 AstraZeneca Description, Business Overview
4.7.3 AstraZeneca Oncology Drugs Products Offered
4.7.4 AstraZeneca Oncology Drugs Revenue and Gross Margin (2017-2022)
4.7.5 AstraZeneca Oncology Drugs Revenue by Product in 2021
4.7.6 AstraZeneca Oncology Drugs Revenue by Application in 2021
4.7.7 AstraZeneca Oncology Drugs Revenue by Geographic Area in 2021
4.7.8 AstraZeneca Recent Development
4.8 Pfizer
4.8.1 Pfizer Corporation Information
4.8.2 Pfizer Description, Business Overview
4.8.3 Pfizer Oncology Drugs Products Offered
4.8.4 Pfizer Oncology Drugs Revenue and Gross Margin (2017-2022)
4.8.5 Pfizer Oncology Drugs Revenue by Product in 2021
4.8.6 Pfizer Oncology Drugs Revenue by Application in 2021
4.8.7 Pfizer Oncology Drugs Revenue by Geographic Area in 2021
4.8.8 Pfizer Recent Development
4.9 Amgen
4.9.1 Amgen Corporation Information
4.9.2 Amgen Description, Business Overview
4.9.3 Amgen Oncology Drugs Products Offered
4.9.4 Amgen Oncology Drugs Revenue and Gross Margin (2017-2022)
4.9.5 Amgen Oncology Drugs Revenue by Product in 2021
4.9.6 Amgen Oncology Drugs Revenue by Application in 2021
4.9.7 Amgen Oncology Drugs Revenue by Geographic Area in 2021
4.9.8 Amgen Recent Development
4.10 Eli Lilly
4.10.1 Eli Lilly Corporation Information
4.10.2 Eli Lilly Description, Business Overview
4.10.3 Eli Lilly Oncology Drugs Products Offered
4.10.4 Eli Lilly Oncology Drugs Revenue and Gross Margin (2017-2022)
4.10.5 Eli Lilly Oncology Drugs Revenue by Product in 2021
4.10.6 Eli Lilly Oncology Drugs Revenue by Application in 2021
4.10.7 Eli Lilly Oncology Drugs Revenue by Geographic Area in 2021
4.10.8 Eli Lilly Recent Development
4.11 AbbVie
4.11.1 AbbVie Corporation Information
4.11.2 AbbVie Description, Business Overview
4.11.3 AbbVie Oncology Drugs Products Offered
4.11.4 AbbVie Oncology Drugs Revenue and Gross Margin (2017-2022)
4.11.5 AbbVie Oncology Drugs Revenue by Product in 2021
4.11.6 AbbVie Oncology Drugs Revenue by Application in 2021
4.11.7 AbbVie Oncology Drugs Revenue by Geographic Area in 2021
4.11.8 AbbVie Recent Development
4.12 Takeda
4.12.1 Takeda Corporation Information
4.12.2 Takeda Description, Business Overview
4.12.3 Takeda Oncology Drugs Products Offered
4.12.4 Takeda Oncology Drugs Revenue and Gross Margin (2017-2022)
4.12.5 Takeda Oncology Drugs Revenue by Product in 2021
4.12.6 Takeda Oncology Drugs Revenue by Application in 2021
4.12.7 Takeda Oncology Drugs Revenue by Geographic Area in 2021
4.12.8 Takeda Recent Development
4.13 Astellas
4.13.1 Astellas Corporation Information
4.13.2 Astellas Description, Business Overview
4.13.3 Astellas Oncology Drugs Products Offered
4.13.4 Astellas Oncology Drugs Revenue and Gross Margin (2017-2022)
4.13.5 Astellas Oncology Drugs Revenue by Product in 2021
4.13.6 Astellas Oncology Drugs Revenue by Application in 2021
4.13.7 Astellas Oncology Drugs Revenue by Geographic Area in 2021
4.13.8 Astellas Recent Development
4.14 Ipsen
4.14.1 Ipsen Corporation Information
4.14.2 Ipsen Description, Business Overview
4.14.3 Ipsen Oncology Drugs Products Offered
4.14.4 Ipsen Oncology Drugs Revenue and Gross Margin (2017-2022)
4.14.5 Ipsen Oncology Drugs Revenue by Product in 2021
4.14.6 Ipsen Oncology Drugs Revenue by Application in 2021
4.14.7 Ipsen Oncology Drugs Revenue by Geographic Area in 2021
4.14.8 Ipsen Recent Development
4.15 Sanofi
4.15.1 Sanofi Corporation Information
4.15.2 Sanofi Description, Business Overview
4.15.3 Sanofi Oncology Drugs Products Offered
4.15.4 Sanofi Oncology Drugs Revenue and Gross Margin (2017-2022)
4.15.5 Sanofi Oncology Drugs Revenue by Product in 2021
4.15.6 Sanofi Oncology Drugs Revenue by Application in 2021
4.15.7 Sanofi Oncology Drugs Revenue by Geographic Area in 2021
4.15.8 Sanofi Recent Development
4.16 Bayer
4.16.1 Bayer Corporation Information
4.16.2 Bayer Description, Business Overview
4.16.3 Bayer Oncology Drugs Products Offered
4.16.4 Bayer Oncology Drugs Revenue and Gross Margin (2017-2022)
4.16.5 Bayer Oncology Drugs Revenue by Product in 2021
4.16.6 Bayer Oncology Drugs Revenue by Application in 2021
4.16.7 Bayer Oncology Drugs Revenue by Geographic Area in 2021
4.16.8 Bayer Recent Development
4.17 Biogen Idec
4.17.1 Biogen Idec Corporation Information
4.17.2 Biogen Idec Description, Business Overview
4.17.3 Biogen Idec Oncology Drugs Products Offered
4.17.4 Biogen Idec Oncology Drugs Revenue and Gross Margin (2017-2022)
4.17.5 Biogen Idec Oncology Drugs Revenue by Product in 2021
4.17.6 Biogen Idec Oncology Drugs Revenue by Application in 2021
4.17.7 Biogen Idec Oncology Drugs Revenue by Geographic Area in 2021
4.17.8 Biogen Idec Recent Development
4.18 Teva
4.18.1 Teva Corporation Information
4.18.2 Teva Description, Business Overview
4.18.3 Teva Oncology Drugs Products Offered
4.18.4 Teva Oncology Drugs Revenue and Gross Margin (2017-2022)
4.18.5 Teva Oncology Drugs Revenue by Product in 2021
4.18.6 Teva Oncology Drugs Revenue by Application in 2021
4.18.7 Teva Oncology Drugs Revenue by Geographic Area in 2021
4.18.8 Teva Recent Development
4.19 Otsuka
4.19.1 Otsuka Corporation Information
4.19.2 Otsuka Description, Business Overview
4.19.3 Otsuka Oncology Drugs Products Offered
4.19.4 Otsuka Oncology Drugs Revenue and Gross Margin (2017-2022)
4.19.5 Otsuka Oncology Drugs Revenue by Product in 2021
4.19.6 Otsuka Oncology Drugs Revenue by Application in 2021
4.19.7 Otsuka Oncology Drugs Revenue by Geographic Area in 2021
4.19.8 Otsuka Recent Development
4.20 Eisai
4.20.1 Eisai Corporation Information
4.20.2 Eisai Description, Business Overview
4.20.3 Eisai Oncology Drugs Products Offered
4.20.4 Eisai Oncology Drugs Revenue and Gross Margin (2017-2022)
4.20.5 Eisai Oncology Drugs Revenue by Product in 2021
4.20.6 Eisai Oncology Drugs Revenue by Application in 2021
4.20.7 Eisai Oncology Drugs Revenue by Geographic Area in 2021
4.20.8 Eisai Recent Development
4.21 Merck KGaA
4.21.1 Merck KGaA Corporation Information
4.21.2 Merck KGaA Description, Business Overview
4.21.3 Merck KGaA Oncology Drugs Products Offered
4.21.4 Merck KGaA Oncology Drugs Revenue and Gross Margin (2017-2022)
4.21.5 Merck KGaA Oncology Drugs Revenue by Product in 2021
4.21.6 Merck KGaA Oncology Drugs Revenue by Application in 2021
4.21.7 Merck KGaA Oncology Drugs Revenue by Geographic Area in 2021
4.21.8 Merck KGaA Recent Development
4.22 Gilead Sciences
4.22.1 Gilead Sciences Corporation Information
4.22.2 Gilead Sciences Description, Business Overview
4.22.3 Gilead Sciences Oncology Drugs Products Offered
4.22.4 Gilead Sciences Oncology Drugs Revenue and Gross Margin (2017-2022)
4.22.5 Gilead Sciences Oncology Drugs Revenue by Product in 2021
4.22.6 Gilead Sciences Oncology Drugs Revenue by Application in 2021
4.22.7 Gilead Sciences Oncology Drugs Revenue by Geographic Area in 2021
4.22.8 Gilead Sciences Recent Development
5 Breakdown Data by Type
5.1 Global Oncology Drugs Revenue by Type (2017-2022)
5.2 Global Oncology Drugs Revenue Forecast by Type (2023-2028)
5.3 Oncology Drugs Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Oncology Drugs Revenue by Application (2017-2022)
6.2 Global Oncology Drugs Revenue Forecast by Application (2023-2028)
6.3 Oncology Drugs Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Oncology Drugs Market Size YoY Growth 2017-2028
7.2 North America Oncology Drugs Market Facts & Figures by Country (2017-2028)
7.3 North America Oncology Drugs Revenue by Type (2017-2022)
7.4 North America Oncology Drugs Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Oncology Drugs Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Oncology Drugs Revenue by Type (2017-2022)
8.4 Asia-Pacific Oncology Drugs Revenue by Application (2017-2022)
9 Europe
9.1 Europe Oncology Drugs Market Size YoY Growth 2017-2028
9.2 Europe Oncology Drugs Market Facts & Figures by Country (2017-2028)
9.3 Europe Oncology Drugs Revenue by Type (2017-2022)
9.4 Europe Oncology Drugs Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Oncology Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Oncology Drugs Market Facts & Figures by Country (2017-2028)
10.3 Latin America Oncology Drugs Revenue by Type (2017-2022)
10.4 Latin America Oncology Drugs Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Oncology Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Oncology Drugs Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Oncology Drugs Revenue by Type (2017-2022)
11.4 Middle East and Africa Oncology Drugs Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Oncology Drugs Supply Chain Analysis
12.2 Oncology Drugs Key Raw Materials and Upstream Suppliers
12.3 Oncology Drugs Clients Analysis
12.4 Oncology Drugs Sales Channel and Sales Model Analysis
12.4.1 Oncology Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Oncology Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Oncology Drugs Distributors
13 Market Dynamics
13.1 Oncology Drugs Industry Trends
13.2 Oncology Drugs Market Drivers
13.3 Oncology Drugs Market Challenges
13.4 Oncology Drugs Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Chemotherapy
Table 3. Major Companies of Targeted Therapy
Table 4. Major Companies of Immunotherapy (Biologic Therapy)
Table 5. Major Companies of Hormonal Therapy
Table 6. Major Companies of Others
Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Oncology Drugs Market Size by Region (US$ Million): 2022 VS 2028
Table 9. Global Oncology Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Oncology Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Oncology Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 12. Oncology Drugs Revenue Share by Company (2017-2022)
Table 13. Ranking of Global Top Oncology Drugs Players by Revenue (US$ Million) in 2021
Table 14. Global Oncology Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 15. Global Oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Drugs as of 2021)
Table 16. Global Oncology Drugs Companies Headquarters
Table 17. Global Oncology Drugs Companies Product & Service
Table 18. Date of International Companies Enter into Oncology Drugs Market
Table 19. Global Oncology Drugs Mergers & Acquisitions, Expansion Plans
Table 20. Roche Corporation Information
Table 21. Roche Description and Business Overview
Table 22. Roche Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 23. Roche Oncology Drugs Product
Table 24. Roche Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 25. Roche Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 26. Roche Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 27. Roche Recent Development
Table 28. Celgene Corporation Information
Table 29. Celgene Description and Business Overview
Table 30. Celgene Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 31. Celgene Oncology Drugs Product
Table 32. Celgene Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 33. Celgene Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 34. Celgene Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 35. Celgene Recent Development
Table 36. Novartis Corporation Information
Table 37. Novartis Description and Business Overview
Table 38. Novartis Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 39. Novartis Oncology Drugs Product
Table 40. Novartis Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 41. Novartis Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 42. Novartis Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 43. Novartis Recent Development
Table 44. Bristol-Myers Squibb Corporation Information
Table 45. Bristol-Myers Squibb Description and Business Overview
Table 46. Bristol-Myers Squibb Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 47. Bristol-Myers Squibb Oncology Drugs Product
Table 48. Bristol-Myers Squibb Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 49. Bristol-Myers Squibb Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 50. Bristol-Myers Squibb Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 51. Bristol-Myers Squibb Recent Development
Table 52. Johnson & Johnson Corporation Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 55. Johnson & Johnson Oncology Drugs Product
Table 56. Johnson & Johnson Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 57. Johnson & Johnson Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 58. Johnson & Johnson Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 59. Johnson & Johnson Recent Development
Table 60. Merck & Co. Corporation Information
Table 61. Merck & Co. Description and Business Overview
Table 62. Merck & Co. Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 63. Merck & Co. Oncology Drugs Product
Table 64. Merck & Co. Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 65. Merck & Co. Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 66. Merck & Co. Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 67. AstraZeneca Corporation Information
Table 68. AstraZeneca Description and Business Overview
Table 69. AstraZeneca Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 70. AstraZeneca Oncology Drugs Product
Table 71. AstraZeneca Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 72. AstraZeneca Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 73. AstraZeneca Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 77. Pfizer Oncology Drugs Product
Table 78. Pfizer Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 79. Pfizer Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 80. Pfizer Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 81. Amgen Corporation Information
Table 82. Amgen Description and Business Overview
Table 83. Amgen Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 84. Amgen Oncology Drugs Product
Table 85. Amgen Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 86. Amgen Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 87. Amgen Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 88. Eli Lilly Corporation Information
Table 89. Eli Lilly Description and Business Overview
Table 90. Eli Lilly Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 91. Eli Lilly Oncology Drugs Product
Table 92. Eli Lilly Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 93. Eli Lilly Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 94. Eli Lilly Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 95. AbbVie Corporation Information
Table 96. AbbVie Description and Business Overview
Table 97. AbbVie Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 98. AbbVie Oncology Drugs Product
Table 99. AbbVie Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 100. AbbVie Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 101. AbbVie Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 102. Takeda Corporation Information
Table 103. Takeda Description and Business Overview
Table 104. Takeda Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 105. Takeda Oncology Drugs Product
Table 106. Takeda Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 107. Takeda Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 108. Takeda Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 109. Astellas Corporation Information
Table 110. Astellas Description and Business Overview
Table 111. Astellas Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 112. Astellas Oncology Drugs Product
Table 113. Astellas Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 114. Astellas Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 115. Astellas Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 116. Ipsen Corporation Information
Table 117. Ipsen Description and Business Overview
Table 118. Ipsen Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 119. Ipsen Oncology Drugs Product
Table 120. Ipsen Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 121. Ipsen Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 122. Ipsen Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 123. Sanofi Corporation Information
Table 124. Sanofi Description and Business Overview
Table 125. Sanofi Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 126. Sanofi Oncology Drugs Product
Table 127. Sanofi Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 128. Sanofi Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 129. Sanofi Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 133. Bayer Oncology Drugs Product
Table 134. Bayer Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 135. Bayer Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 136. Bayer Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 137. Biogen Idec Corporation Information
Table 138. Biogen Idec Description and Business Overview
Table 139. Biogen Idec Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 140. Biogen Idec Oncology Drugs Product
Table 141. Biogen Idec Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 142. Biogen Idec Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 143. Biogen Idec Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 144. Teva Corporation Information
Table 145. Teva Description and Business Overview
Table 146. Teva Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 147. Teva Oncology Drugs Product
Table 148. Teva Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 149. Teva Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 150. Teva Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 151. Otsuka Corporation Information
Table 152. Otsuka Description and Business Overview
Table 153. Otsuka Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 154. Otsuka Oncology Drugs Product
Table 155. Otsuka Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 156. Otsuka Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 157. Otsuka Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 158. Eisai Corporation Information
Table 159. Eisai Description and Business Overview
Table 160. Eisai Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 161. Eisai Oncology Drugs Product
Table 162. Eisai Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 163. Eisai Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 164. Eisai Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 165. Merck KGaA Corporation Information
Table 166. Merck KGaA Description and Business Overview
Table 167. Merck KGaA Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 168. Merck KGaA Oncology Drugs Product
Table 169. Merck KGaA Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 170. Merck KGaA Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 171. Merck KGaA Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 172. Gilead Sciences Corporation Information
Table 173. Gilead Sciences Description and Business Overview
Table 174. Gilead Sciences Oncology Drugs Revenue (US$ Million) and Gross Margin (2017-2022)
Table 175. Gilead Sciences Oncology Drugs Product
Table 176. Gilead Sciences Oncology Drugs Revenue Proportion of Oncology Drugs by Product in 2021
Table 177. Gilead Sciences Oncology Drugs Revenue Proportion of Oncology Drugs by Application in 2021
Table 178. Gilead Sciences Oncology Drugs Revenue Proportion of Oncology Drugs by Geographic Area in 2021
Table 179. Global Oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 180. Global Oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 181. Global Oncology Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 182. North America Oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 183. North America Oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 184. North America Oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 185. North America Oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 186. Asia-Pacific Oncology Drugs Revenue by Region (2017-2028) & (US$ Million)
Table 187. Asia-Pacific Oncology Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 188. Asia-Pacific Oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 189. Asia-Pacific Oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 190. Europe Oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 191. Europe Oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 192. Europe Oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 193. Europe Oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 194. Latin America Oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 195. Latin America Oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 196. Latin America Oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 197. Latin America Oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 198. Middle East and Africa Oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 199. Middle East and Africa Oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 200. Middle East and Africa Oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 201. Middle East and Africa Oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 202. Oncology Drugs Key Raw Materials, Industry Status and Trend
Table 203. Oncology Drugs Key Raw Materials and Upstream Suppliers
Table 204. Oncology Drugs Clients Status and Trend
Table 205. Oncology Drugs Typical Clients
Table 206. Oncology Drugs Distributors
Table 207. Oncology Drugs Market Trends
Table 208. Oncology Drugs Market Drivers
Table 209. Oncology Drugs Market Challenges
Table 210. Oncology Drugs Market Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Drugs Produ
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs